Evidence map›Paper›PMID 32670009›Full record

ArticleFrontiers in neuroscience2020

Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson's Disease Model Induced by 6-OHDA.

Shengyan Tai, Qian Zheng, Suzhen Zhai, Ting Cai, Li Xu, Lizhu Yang, Ling Jiao, Chunlin Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Synthetic Cyclic CAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS & neurological disorders drug targets · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Synthetic Cyclic CAntioxidants (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism.International journal of molecular sciences · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shengyan TaiDepartment of Biology, College of Basic Medical, Guizhou Medical University, Guiyang, China.
Qian ZhengDepartment of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Suzhen ZhaiDepartment of Biology, College of Basic Medical, Guizhou Medical University, Guiyang, China.
Ting CaiDepartment of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Li XuDepartment of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Lizhu YangDepartment of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Ling JiaoDepartment of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Chunlin ZhangDepartment of Biology, College of Basic Medical, Guizhou Medical University, Guiyang, China.
Guiyang Medical University · CNAffiliated Hospital of Guizhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disruption of neuronal iron homeostasis and oxidative stress are related to the pathogenesis of Parkinson's disease (PD). Alpha-lipoic acid (ALA) is a naturally occurring enzyme cofactor with antioxidant and iron chelator properties and has many known effects. ALA has neuroprotective effects on PD. However, its underlying mechanism remains unclear. In the present study, we established PD models induced by 6-hydroxydopamine (6-OHDA) to explore the neuroprotective ability of ALA and its underlying mechanism

Indexed as

alpha-lipoic acidchelation ironiron homeostasisoxidative stressParkinson’s disease

Identifiers

PMID32670009
PMCPMC7330090
OpenAlexW3037026015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.